Karyopharm Therapeutics reported $-125977000 in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 718.15M 44.88M
Amgen AMGN:US $ 8217M 30M
AstraZeneca AZN:LN 39744M 24068M
Astrazeneca AZN:US $ 39744M 24068M
Avrobio Inc AVRO:US $ 193.57M 27.42M
Biocryst Pharmaceuticals BCRX:US $ -147.04M 40.97M
Bristol Myers Squibb BMY:US $ 37213M 405M
Eli Lilly And LLY:US $ 7757M 1312.6M
Enanta Pharmaceuticals ENTA:US $ 399.43M 18.42M
Epizyme EPZM:US $ 15.38M 52.25M
GlaxoSmithKline GSK:LN 15426M 49M
Karyopharm Therapeutics KPTI:US $ -125977000 42.84M
Macrogenics MGNX:US $ 291.44M 27.61M
Mirati Therapeutics MRTX:US $ 1084.03M 44.9M
Nektar Therapeutics NKTR:US $ 801.54M 103.44M
Novartis NVS:US $ 56771M 2729M
Novartis NOVN:VX SF 56771M 2729M
Regeneron Pharmaceuticals REGN:US $ 17258M 2130.7M
Sangamo Biosciences SGMO:US $ 406.02M 39.44M
Takeda 4502:JP Y 5323935M 24161M
Tg Therapeutics TGTX:US $ 311.52M 71.61M
Ultragenyx Pharmaceutical RARE:US $ 933.67M 38.5M
Xencor XNCR:US $ 618.86M 28.08M
YTE INCY:US $ 3148.66M 212.8M